This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

John Wayne Cancer Institute Auxiliary To Honor Michael Sitrick With "The Duke" Award At The 28th Annual Odyssey Ball

LOS ANGELES, April 3, 2013 /PRNewswire/ -- Michael Sitrick, Chairman and CEO of Sitrick and Company, will be honored with the Special Service Award, "The Duke," at the 28 th annual Odyssey Ball, the yearly fundraising event that benefits the John Wayne Cancer Institute (JWCI) at Saint John's Health Center.  This year's gala will be held April 13 at the Four Seasons Beverly Wilshire Hotel and will feature a special performance by singer and voice actress Rachael MacFarlane.  The Odyssey Ball is organized by the John Wayne Cancer Institute Auxiliary currently helmed by President Anita Swift, granddaughter of John Wayne.   Gala co-chairs are Susan Veerman and Cynde Wilen.

" Mike Sitrick embodies all that " The Duke" Award symbolizes," said Patrick Wayne, Chairman of the Board at JWCI.  "In addition to his family's philanthropy and the work he has done for Saint John's Health Center, he has served as a senior advisor and member of the Board of Directors of Abraxis BioScience, developer and distributor of Abraxane, a revolutionary cancer drug.  We are thrilled to honor him for his commitment to the fight against cancer."

Sitrick, an internationally recognized expert in the strategic use of communications, is the founder, Chairman and CEO of Sitrick and Company and has provided advice and counsel to more than 1,000 companies, including some of the nation's largest corporations, and some of the nation's highest profile individuals.  Sitrick serves on the Board of Trustees of the Saint John's Health Center Foundation, Nant Pharma and the nonprofit Chan Soon-Shiong Institute for Advanced Health. 

Proceeds from this year's Odyssey Ball will support JWCI's Oncology Fellowship Program which is a vital part of The Institute's mission to train future leaders in cancer research and treatment and is the only center in California (and one of only eight nationally), accredited to provide advanced degree training in complex cancer surgeries.  The Family of John Wayne, through the John Wayne Cancer Foundation, has pledged $500,000 to the Fellowship Program. 

Since 1981, the John Wayne name has been committed by the Wayne family to groundbreaking cancer research and education in memory of their father, who died of cancer.  The courageous researchers at the JWCI have changed the way the world approaches cancer research and treatment yielding new breakthroughs that have helped doctors detect cancer sooner, stage it more precisely and treat it more effectively.  Today, the Institute is enhancing its world renowned programs focusing on melanoma, breast, and gastrointestinal cancers as well as extending its expertise in cancer research, clinical practice and education to include brain tumors and prostate cancer.  With its unique ability to rapidly turn scientific breakthroughs into innovative approaches to treatment and early detection, the Institute provides immediate hope to cancer patients around the globe. Visit www.jwci.org.

 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs